Skip to main content
Clinical Trials/NCT00805402
NCT00805402
Completed
Not Applicable

Interest of Flow Cytometry for the Diagnosis, the Follow up and SIT Arrest of Hymenoptera Venom Allergy

University Hospital, Limoges1 site in 1 country75 target enrollmentJuly 1, 2008
ConditionsAllergy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Allergy
Sponsor
University Hospital, Limoges
Enrollment
75
Locations
1
Primary Endpoint
% CD63 expression on basophil membrane by flow Cytometry
Status
Completed
Last Updated
9 months ago

Overview

Brief Summary

The aim of this study is to show that flow cytometry can be an accurate tool to help physicians regarding the diagnosis, the SIT decision and the SIT arrest of hymenoptera venom allergy.

75 patients having a story of reaction to hymenoptera venom will be selected for this trial.

Blood samples will be analyzed at: inclusion visit, Week 1 visit, Week 3 visit, Week 10 and Week 21 visit.

Registry
clinicaltrials.gov
Start Date
July 1, 2008
End Date
July 1, 2010
Last Updated
9 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University Hospital, Limoges
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patient (18 - 70 years)
  • Patient being informed and accepting to participate in the study with signature of informed consent
  • Patients having a clinical systematic and local, loco-regional story of reaction to the piqures of hymenopterans.
  • Patients treated by SIT for at least 5 years
  • Patients benefiting from a national insurance health

Exclusion Criteria

  • Pregnant woman or who breast-feed
  • Patient under antihistaminic or corticoid for less than 8 days before the blood drawing
  • Protected Patient
  • Patient not having given his agreement after it was informed

Outcomes

Primary Outcomes

% CD63 expression on basophil membrane by flow Cytometry

Time Frame: Inclusion , Week 1, Week 3, Week 10 and Week 21 visits

Secondary Outcomes

  • Blood blocking factors level(Week 1, Week 3, Week 10 and Week 21 visits)

Study Sites (1)

Loading locations...

Similar Trials